The total number of records retrieved from this search are 14. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_5399	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu	In-vitro result46.047% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5400	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, one fold dilution	In-vitro result46.047% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5401	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, two fold dilution	In-vitro result73.183% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5402	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, three fold dilution	In-vitro result58.012% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5403	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, four fold dilution	In-vitro result27.350% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5404	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, five fold dilution	In-vitro result19.658% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5405	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, six fold dilution	In-vitro result14.529% cell growth inhibition after 72 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5406	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, one fold dilution	In-vitro result87.81% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5407	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, two fold dilution	In-vitro result90.101% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5408	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, three fold dilution	In-vitro result74.746% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5409	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, four fold dilution	In-vitro result48.477% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5410	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, five fold dilution	In-vitro result36.421% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5411	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu, six fold dilution	In-vitro result23.477% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663
IDOV_5412	Virus nameMeasles virus	Virus strainSchwarz vaccine stain	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineICCMGR cell bank unit, Iraq	Origin of cell lineHuman glioblastoma cell line	Cell lineANGM5	Concentration of cell line7.0E+3 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration3.4 × 10⁵ pfu	In-vitro result35.279% cell growth inhibition after 120 hours	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedInduction of apoptosis as measured by mitochondrial permeability apoptosis assay	Immunogenic effectNA	Clinical trialNA	PMID27512663